Before the United States will consider giving AIDS funding to another country, the President's Emergency Plan for AIDS Relief requires the foreign government to create and implement a national AIDS strategy. "At the core of the implementation strategy," the requirements explain, "is a robust ongoing in-country planning effort" meant to "identify relevant U.S. government agencies, existing resources, needs, gaps, partners, programs, objectives, performance measures, staffing, and technical assistance requirements."
Locally funded needle exchange is officially returning to Washington. Dr. Shannon Hader, the District's HIV/AIDS czar, yesterday named the four groups who will share $494,000 in funding. The majority of the funding is slated for PreventionWorks!, the only organization in D.C. that was doing needle exchange during a decade-long, federally imposed funding ban specifically targeting the nation's capital. For the other three groups, the funding will allow them to incorporate needle exchange into their existing programs.
There's an unusual hero emerging from the morass that is contemporary Zimbabwe: Jacob Zuma.
The president of South Africa's African National Congress party, and presidential heir apparent, this week stepped up his criticism of the Zimbabwean government and President Robert Mugabe, calling for the release of results from last month's presidential election.
First Congress lifted the ban on needle-exchange funding in D.C. last December. Then yesterday brought news that lawmakers might lift a decades-old ban against HIV-positive people visiting or immigrating to the United States. What’s happening on the Hill? Are legislators ceding their bunker-mentality approach to domestic AIDS policy?
The most promising AIDS vaccine in the pipeline was a bust -- and might actually have put participants in field tests at greater risk of becoming infected. Other trials of similar vaccines have also been called off, which raises an important question: is funding for AIDS vaccines a waste of money?